Mukherji A, Juhling F, Simanjuntak Y, Crouchet E, Del Zompo F, Teraoka Y
Nat Commun. 2024; 15(1):7486.
PMID: 39209804
PMC: 11362569.
DOI: 10.1038/s41467-024-51698-8.
Pierce B, Felbinger N, Metcalf M, Toth E, Ofek G, Fuerst T
Viruses. 2024; 16(5).
PMID: 38793684
PMC: 11125608.
DOI: 10.3390/v16050803.
Wang D, Phu A, McKee K, Strasser S, Sheils S, Weltman M
Open Forum Infect Dis. 2024; 11(4):ofae155.
PMID: 38651137
PMC: 11034952.
DOI: 10.1093/ofid/ofae155.
Chang H, Wang S, Kuo H, Sheu M, Feng I, Ho C
Int J Hepatol. 2024; 2024:3184892.
PMID: 38510786
PMC: 10954363.
DOI: 10.1155/2024/3184892.
Crouchet E, Baumert T
J Hepatol. 2023; 80(2):184-187.
PMID: 37088307
PMC: 7615597.
DOI: 10.1016/j.jhep.2023.04.016.
Complicating cure: How Australian criminal law shapes imagined post-hepatitis C futures.
Seear K, Mulcahy S, Kagan D, Lenton E, Fraser S, Valentine K
Sociol Health Illn. 2022; 45(1):179-195.
PMID: 36254737
PMC: 10092810.
DOI: 10.1111/1467-9566.13562.
The Lived Experience of Patients Utilizing Second-Generation Direct-Acting Antiviral for Treatment of Chronic Hepatitis C Virus Infection: A Phenomenological Analysis.
Nascimento Y, Silva L, Oliveira D
Int J Environ Res Public Health. 2022; 19(19).
PMID: 36231842
PMC: 9566709.
DOI: 10.3390/ijerph191912540.
Predictive validity in drug discovery: what it is, why it matters and how to improve it.
Scannell J, Bosley J, Hickman J, Dawson G, Truebel H, Ferreira G
Nat Rev Drug Discov. 2022; 21(12):915-931.
PMID: 36195754
DOI: 10.1038/s41573-022-00552-x.
Uptake and factors associated with direct-acting antiviral therapy for hepatitis C and treatment outcomes among Canadian immigrants: A retrospective cohort analysis.
Petrosyan Y, Simmons J, Kelly E, Cooper C
Can Liver J. 2022; 5(3):388-401.
PMID: 36133896
PMC: 9473565.
DOI: 10.3138/canlivj-2021-0037.
Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CanHepC), the Canadian Association of Hepatology Nurses (CAHN), and the Canadian NASH Network 2022 Abstracts.
Can Liver J. 2022; 5(2):169-317.
PMID: 35991483
PMC: 9236590.
DOI: 10.3138/canlivj.5.2.abst.
Enhanced Liver Fibrosis Score: Is It Useful for Evaluation of Fibrosis Severity in Chronic Hepatitis C Infection?.
Kumar M, George R, Vaithiyam V, Sakhuja P, Dahale A, Dayal A
Cureus. 2022; 14(1):e21168.
PMID: 35165618
PMC: 8831389.
DOI: 10.7759/cureus.21168.
The Bank Vole ()-Small Animal Model for Hepacivirus Infection.
Rohrs S, Begeman L, Straub B, Boadella M, Hanke D, Wernike K
Viruses. 2021; 13(12).
PMID: 34960690
PMC: 8708279.
DOI: 10.3390/v13122421.
HCV Activates Somatic L1 Retrotransposition-A Potential Hepatocarcinogenesis Pathway.
Sudhindar P, Wainwright D, Saha S, Howarth R, McCain M, Bury Y
Cancers (Basel). 2021; 13(20).
PMID: 34680227
PMC: 8533982.
DOI: 10.3390/cancers13205079.
Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C-Related Advanced Fibrosis and Cirrhosis.
Kilany S, Ata L, Gomaa A, Sabry A, Nada A, Tharwa E
J Hepatocell Carcinoma. 2021; 8:925-935.
PMID: 34408991
PMC: 8367200.
DOI: 10.2147/JHC.S295330.
The 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus.
Lin C, Chien R, Sheen I
Biomed J. 2021; 44(5):567-569.
PMID: 34245922
PMC: 8640543.
DOI: 10.1016/j.bj.2021.07.001.
Impact of sofosbuvir and daclastavir on health-related quality of life in patients co-infected with hepatitis C and human immunodeficiency virus.
Yunihastuti E, Amelia F, Hapsari A, Wicaksana B, Natali V, Widhani A
Health Qual Life Outcomes. 2021; 19(1):154.
PMID: 34039353
PMC: 8152304.
DOI: 10.1186/s12955-021-01777-x.
Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development.
Virzi A, Gonzalez-Motos V, Tripon S, Baumert T, Lupberger J
J Clin Med. 2021; 10(5).
PMID: 33801181
PMC: 7957739.
DOI: 10.3390/jcm10050977.
The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and Persistence.
Ghany M, Lok A, Dienstag J, Feinstone S, Hoofnagle J, Liang T
Hepatology. 2021; 74(5):2813-2823.
PMID: 33784424
PMC: 9577909.
DOI: 10.1002/hep.31830.
The Nobel Prize in Medicine 2020 for the Discovery of Hepatitis C Virus: Transforming Hepatology.
Baumert T
J Hepatol. 2020; 73(6):1303-1305.
PMID: 33213742
PMC: 7613428.
DOI: 10.1016/j.jhep.2020.10.017.
Perturbation of the circadian clock and pathogenesis of NAFLD.
Mukherji A, Dachraoui M, Baumert T
Metabolism. 2020; 111S:154337.
PMID: 32795560
PMC: 7613429.
DOI: 10.1016/j.metabol.2020.154337.
